Section 503B applies to human drug compounding within an outsourcing facility. The law defines an outsourcing facility as a facility at one geographic location or address that is engaged in the compounding of sterile drugs; has elected to register as an outsourcing facility; and complies with all of the requirements of section 503B.
Terms of Use
Privacy Statement
Cookie Consent Notice
Website Accessibility
Do Not Sell or Share My Personal Information
We're working to improve website accessibility. Need help? Call 800.331.2498 or view our Accessibility Notice.